A single specialty claim can materially affect a self-funded plan. US Med Access helps brokers, consultants, and TPAs identify medication-level reference differences that may warrant independent clinical, legal, regulatory, and logistics review.
We do not replace your pharmacy benefit manager (PBM). We act as an out-of-country specialty drug channel for high-cost claims, giving plans a compliant tool to reduce risk.
The TPA, broker, or employer reviews pharmacy claims to identify candidates taking high-cost specialty drugs (e.g. oncology, chronic immunology, rare diseases) listed in our EU dispensing pharmacy catalog.
Enrolling is completely voluntary for the member. When they opt in, we coordinate the collection of their US prescription and introduce them to the licensed European dispensing pharmacy.
The EU dispensing pharmacy dispenses and ships the medication directly to the member's home or supervising clinic via cold chain courier, with shipping paid by the plan sponsor at a fraction of US cost.
By connecting with international pharmacy prices, self-funded employers maintain member health benefits without compromising financial stability:
Identify selected packages where dated EU reference figures differ materially from captured US cash benchmarks and merit a deeper review.
Surface FDA personal-importation context and the product, prescription, importer, documentation, and destination questions that require case-specific review.
Give plan stakeholders clearer medication, package, pricing, and operational information before deciding whether a voluntary program is appropriate.
Start with a medication-only list containing brand, active ingredient, strength, quantity, and current benchmark. Do not submit member names, prescriptions, diagnoses, or protected health information through the public form.
Review the international sourcing buyer framework · See how package-level price comparisons work